Market Shifts: Sherwin-Williams Joins Dow, Strong Gains for Key Players
Generated by AI AgentAinvest Market Brief
Monday, Nov 4, 2024 5:30 pm ET1min read
MNST--
SHW--
1. The Sherwin-Williamsmpany (NYSE: SHW)
The Sherwin-Williamsmpany gained solidly by 4.59%. Sherwin-Williams replaces Dow Chemical in the Dow Jones Industrial Average, effective November 8, to enhance semiconductor and materials industry representation. Sherwin-Williams reported Q3 2024 revenue of $178.01 billion.
2. Monster Beverage (Nasdaq: MNST)
Monster Beverage gained solidly by 3.37%. JP Morgan maintains a neutral rating on Monster Beverage with a price target of $49.00. B of A Securities retains a buy rating, targeting $57.00. Roth MKM keeps a neutral stance at $50.00. Truist Securities holds a sell rating with a $40.00 target.
3. Ambev S.A. (NYSE: ABEV)
Ambev S.A. gained solidly by 3.26%. Ambev reported its Third Quarter fiscal 2024 results with significant achievements. The company had earlier reported its First and Second Quarter results this year, showing steady performance. UBS maintains a buy rating for Ambev with a price target of $2.90.
4. Exxon Mobil (NYSE: XOM)
Exxon Mobil gained solidly by 3.18%. Exxon Mobil reported Q3 2024 revenue of $266.16 billion with a 7.61% year-over-year net profit decrease. TD Cowen maintained a Buy rating with a $127 target, RBC Capital reiterated Sector Perform with a $120 target. Exxon Mobil increased fossil fuel production alongside Chevron despite weak oil prices.
5. Trip Group Limited (Nasdaq: TCOM)
Trip Group Limited gained solidly by 3.15%. Trip.com enters strategic partnership with Caesars Bay to enhance destination operations and tourism product innovation. Bernstein initiates coverage on Trip.com with Outperform rating and $85 target. China's visa-free expansion boosts Trip.com’s prospects.
The Sherwin-Williamsmpany gained solidly by 4.59%. Sherwin-Williams replaces Dow Chemical in the Dow Jones Industrial Average, effective November 8, to enhance semiconductor and materials industry representation. Sherwin-Williams reported Q3 2024 revenue of $178.01 billion.
2. Monster Beverage (Nasdaq: MNST)
Monster Beverage gained solidly by 3.37%. JP Morgan maintains a neutral rating on Monster Beverage with a price target of $49.00. B of A Securities retains a buy rating, targeting $57.00. Roth MKM keeps a neutral stance at $50.00. Truist Securities holds a sell rating with a $40.00 target.
3. Ambev S.A. (NYSE: ABEV)
Ambev S.A. gained solidly by 3.26%. Ambev reported its Third Quarter fiscal 2024 results with significant achievements. The company had earlier reported its First and Second Quarter results this year, showing steady performance. UBS maintains a buy rating for Ambev with a price target of $2.90.
4. Exxon Mobil (NYSE: XOM)
Exxon Mobil gained solidly by 3.18%. Exxon Mobil reported Q3 2024 revenue of $266.16 billion with a 7.61% year-over-year net profit decrease. TD Cowen maintained a Buy rating with a $127 target, RBC Capital reiterated Sector Perform with a $120 target. Exxon Mobil increased fossil fuel production alongside Chevron despite weak oil prices.
5. Trip Group Limited (Nasdaq: TCOM)
Trip Group Limited gained solidly by 3.15%. Trip.com enters strategic partnership with Caesars Bay to enhance destination operations and tourism product innovation. Bernstein initiates coverage on Trip.com with Outperform rating and $85 target. China's visa-free expansion boosts Trip.com’s prospects.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet